Iperionx LTD 4 Filing
Ticker: IPX · Form: 4 · Filed: Mar 30, 2026 · CIK: 0001898601
| Field | Detail |
|---|---|
| Company | Iperionx LTD (IPX) |
| Form Type | 4 |
| Filed Date | Mar 30, 2026 |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $6, $7, $8 |
| Sentiment | neutral |
Sentiment: neutral
FAQ
What type of filing is this?
This is a 4 filing submitted by Iperionx LTD (ticker: IPX) to the SEC on Mar 30, 2026.
What are the key financial figures in this filing?
Key dollar amounts include: $6 (Number of Shares Performance Rights (A$6) $ 6 (6) 04/10/2029 04/10/2030 Ordinary); $7 (435,806 435,806 D Performance Rights (A$7) $ 7 (6) 04/10/2029 04/10/2030 Ordinary); $8 (435,806 435,806 D Performance Rights (A$8) $ 8 (6) 04/10/2029 04/10/2030 Ordinary).
How long is this filing?
Iperionx LTD's 4 filing is 2 pages with approximately 715 words. Estimated reading time is 3 minutes.
Where can I view the full 4 filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Stats: 715 words · 3 min read · ~2 pages · Grade level 7.9 · Accepted 2026-03-30 08:38:13
Key Financial Figures
- $6 — Number of Shares Performance Rights (A$6) $ 6 (6) 04/10/2029 04/10/2030 Ordinary
- $7 — 435,806 435,806 D Performance Rights (A$7) $ 7 (6) 04/10/2029 04/10/2030 Ordinary
- $8 — 435,806 435,806 D Performance Rights (A$8) $ 8 (6) 04/10/2029 04/10/2030 Ordinary
Filing Documents
- primary_doc.html (4)
- primary_doc.xml (4) — 10KB
- 0001864247-26-000004.txt ( ) — 11KB
From the Filing
SEC FORM 4 SEC Form 4 FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10. 1. Name and Address of Reporting Person * Arima Anastasios (Last) (First) (Middle) 1092 CONFROY DRIVE (Street) SOUTH BOSTON VIRGINIA 24592 (City) (State) (Zip) UNITED STATES (Country) 2. Issuer Name and Ticker or Trading Symbol IPERIONX Ltd [ IPX ] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) Chief Executive Officer 2a. Foreign Trading Symbol 3. Date of Earliest Transaction (Month/Day/Year) 03/27/2026 6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person 4. If Amendment, Date of Original Filed (Month/Day/Year) Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Ordinary Shares (1) 03/27/2026 P 467,000 A $ 3.198 (2) 12,206,782 D American Depository Shares (3) 03/27/2026 P 12,800 A $ 23.4097 (4) 12,800 D Restricted Stock Units (RSUs) (5) 738,576 D Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Performance Rights (A$6) $ 6 (6) 04/10/2029 04/10/2030 Ordinary Shares (1) 435,806 435,806 D Performance Rights (A$7) $ 7 (6) 04/10/2029 04/10/2030 Ordinary Shares (1) 435,806 435,806 D Performance Rights (A$8) $ 8 (6) 04/10/2029 04/10/2030 Ordinary Shares (1) 435,806 435,806 D Explanation of Responses: 1. Ordinary Shares are traded on the Australian Stock Exchange (ASX) 2. This is the average price of shares purchased. The price shown is in Australian dollars. 3. American Depository Shares (ADS) are traded on the NASDAQ. One ADS is convertible into 10 Ordinary Shares (which trade on the Australian Stock Exchange). 4. This is the average price of shares purchased. 5. 318,666 vest in December 2026; 419,910 vest in April 2028 6. Australian dollars. Michael Spath 03/30/2026 ** Signature of Reporting Person Date Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. * If the form is filed by more than one reporting person, see Instruction 4 (b)(v). ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. * Form 4: SEC 1474 (03-26)